Japanese Electric Utilities Stock News

TSE:6178
TSE:6178Insurance

Japan Post Holdings TSE 6178 Valuation Check As Board Weighs Simple Absorption Company Split

Board meeting puts corporate restructuring in focus Japan Post Holdings (TSE:6178) has scheduled a February 26, 2026 board meeting to consider a simple absorption type company split, a move that could reshape how certain assets and liabilities are organized. See our latest analysis for Japan Post Holdings. That upcoming board meeting lands after a mixed few months, with a 1 day share price return of 2.87% but 7 day and 30 day share price returns of 4.90% and 5.84% declines, set against a...
TSE:7203
TSE:7203Auto

Toyota (TSE:7203) Is Down 6.2% After Cutting Mideast Output Amid US‑Iran Tensions And Leadership Changes - Has The Bull Case Changed?

Toyota Motor recently cut production by nearly 40,000 vehicles for Middle Eastern markets in March and April, citing logistical disruptions linked to the US‑Iran conflict, while also approving new board and executive appointments after its latest General Shareholders' Meeting. This combination of geopolitically driven production adjustments and refreshed leadership highlights how operational risk and governance decisions are increasingly shaping Toyota’s global footprint. We’ll now examine...
TSE:8002
TSE:8002Trade Distributors

Is Marubeni (TSE:8002) Using Fund Partnerships To Quietly Redraw Its Private Markets Strategy?

In early March 2026, Branford Castle Partners and Marubeni Corporation announced that Marubeni would make a significant investment in Branford Castle’s new flagship fund and work together to use Marubeni’s global network, logistics, manufacturing and commodities capabilities to support Branford Castle’s investment platform. The collaboration gives Branford Castle access to one of Japan’s largest sogo shosha, potentially broadening its deal pipeline while underscoring Marubeni’s efforts to...
TSE:4502
TSE:4502Pharmaceuticals

How FDA Priority Review for Rusfertide and Renewed Actos Claims Will Impact Takeda Pharmaceutical (TSE:4502) Investors

In early March 2026, Takeda and Protagonist Therapeutics announced that the U.S. FDA accepted and granted Priority Review to their New Drug Application for rusfertide, a first-in-class hepcidin mimetic for adults with polycythemia vera, while a U.S. court certified a national third-party payor class in long-running Actos litigation over alleged concealment of bladder cancer risks. Together, the potential for rusfertide to reach patients sooner under expedited FDA review and the renewed legal...
TSE:4062
TSE:4062Electronic

Ibiden (TSE:4062) Is Down 9.1% After ¥52.5bn Follow-on Equity Offering for Substrate Capacity

Ibiden Co., Ltd. recently completed a ¥52.47 billion follow-on equity offering of 6,874,700 common shares at ¥7,632 each, following a February 2026 board decision to fund additional capacity for high-performance IC package substrates at its Ono Plant. The addition of SMBC Nikko Securities, Nomura Securities, and Daiwa Securities as co-lead underwriters highlights both the scale of the capital raising and the market’s focus on Ibiden’s server-related substrate expansion plans. We will now...
TSE:6723
TSE:6723Semiconductor

Is Renesas (TSE:6723) Quietly Rewiring Its Automotive Edge With New MCUs and ADAS Wins?

In early March 2026, Renesas Electronics launched the RH850/U2C 32-bit automotive microcontroller built on a 28nm process and confirmed that its R-Car V4H ADAS SoC is powering the Toyota RAV4’s latest driver-assistance and parking systems via a Denso-supplied control unit. Together with new leadership appointments for India and China, these developments underline how Renesas is aligning advanced automotive chips with deeper presence in two of the world’s largest auto and electronics...
TSE:9697
TSE:9697Entertainment

Assessing Capcom (TSE:9697) Valuation After New Resident Evil Requiem GIGABYTE Partnership

Capcom (TSE:9697) is back in focus after GIGABYTE unveiled a Resident Evil Requiem themed hardware collaboration and game bundle, a marketing push that ties the franchise directly to premium PC gaming gear. See our latest analysis for Capcom. Capcom’s recent news, including the Resident Evil Requiem tie up with GIGABYTE and the upcoming board meeting on director changes, comes after a 13.07% 1 month share price return. Its 1 year total shareholder return of 1.99% contrasts with a much...
TSE:5803
TSE:5803Electrical

Is Fujikura (TSE:5803) Using Its Stock Split And Leadership Shake-Up To Reframe Its Capital Strategy?

Fujikura Ltd. recently revised its planned stock split, increasing the ratio from five-for-one to six-for-one with a record date of March 31, 2026, while its Board also approved amendments to the Articles of Incorporation and several board and executive changes, including a new CTO appointment. The combination of a larger stock split and a refreshed leadership structure, including a reallocation of CTO responsibilities and a new outside director candidate with legal and governance expertise,...
TSE:8233
TSE:8233Multiline Retail

Takashimaya Company (TSE:8233) Valuation After Forecasting A Bond Cancellation Loss

Takashimaya Company (TSE:8233) has revised its earnings guidance for the fiscal year ending February 28, 2026, and now expects a loss attributable to owners of the parent after finalizing a large extraordinary loss on bond cancellation. See our latest analysis for Takashimaya Company. The guidance revision comes after a sharp 17.47% 1 month share price decline, even though the 1 year total shareholder return of 57.01% and 5 year total shareholder return of 230.47% point to strong longer term...
TSE:7974
TSE:7974Entertainment

Nintendo (TSE:7974) Is Up 6.0% After Expanding Its Super Mario Galaxy Film Universe - Has The Bull Case Changed?

Illumination and Nintendo Co., Ltd. recently unveiled the final trailer for The Super Mario Galaxy Movie during a Nintendo Direct, confirming an April 2026 global theatrical rollout with an ensemble voice cast including Chris Pratt, Anya Taylor-Joy, Jack Black, and Donald Glover as Yoshi. By expanding its Mario universe on the big screen with returning filmmakers and fresh celebrity talent, Nintendo is deepening its entertainment IP footprint beyond gaming and creating new ways to connect...
TSE:3401
TSE:3401Chemicals

Taking A Fresh Look At Teijin (TSE:3401) Valuation After Recent Share Price Strength

Why Teijin stock is catching investor attention now Teijin (TSE:3401) has drawn fresh interest after recent share price moves, with the stock up around 20% over the past 3 months and showing smaller mixed returns over shorter periods. Those shifts, alongside revenue of ¥909.2b and a reported net income loss of ¥81,603, reflect a company where investors are weighing current profitability against longer term potential in fibers, composites, healthcare and IT. See our latest analysis for...
TSE:9434
TSE:9434Wireless Telecom

How SoftBank’s Telco AI Cloud and Physical AI Strategy Could Impact SoftBank (TSE:9434) Investors

In early March 2026, SoftBank Corp. outlined its Telco AI Cloud vision, shifting from a traditional telecom carrier to an AI-native infrastructure provider that embeds distributed AI processing across data centers, radio networks, and edge environments, with partners including Ericsson, Yaskawa Electric, Mitsubishi Heavy Industries, Northeastern University, Keysight, and zTouch Networks. By turning the network into a computation layer for “Physical AI” and open-sourcing core AI-RAN...
TSE:6857
TSE:6857Semiconductor

Assessing Advantest (TSE:6857) Valuation After Recent Share Price Volatility

Event context and recent performance snapshot With no specific catalyst driving headlines today, Advantest (TSE:6857) is drawing attention for its recent share performance. The stock has moved 4.7% over the past day and declined 6.9% over the past week. See our latest analysis for Advantest. That 4.7% 1 day share price move comes after a softer patch, with a 7 day share price return of 6.9% and a 30 day share price return of 2.3%. However, the 90 day share price return of 18.9% sits alongside...
TSE:6740
TSE:6740Electronic

Japan Display (TSE:6740) Valuation Check After US$13b US Display Factory Headlines

Japan Display (TSE:6740) has jumped into focus after reports that Tokyo and Washington are discussing a potential US display factory tied to a roughly $13b government backed investment package. See our latest analysis for Japan Display. The headlines around a potential US plant come on top of a sharp shift in market sentiment, with a 1 day share price return of 57.69% and a 30 day share price return of 272.73% feeding into a 1 year total shareholder return of 355.56%, so momentum has been...
TSE:2503
TSE:2503Beverage

Does Kirin’s Personalized Gut Microbiome Push Reshape Its Health-Nutrition Strategy (TSE:2503)?

Cowellnex, Kyowa Kirin and Metagen have begun joint research to develop gut microbiota tests and personalized food recommendation algorithms for Japanese individuals, using Cowellnex’s high-precision shotgun metagenomic data accumulated over roughly three years. The collaboration highlights how advanced microbiome analytics could underpin new personalized gut health services, potentially expanding Kirin’s reach in science-based health and nutrition solutions. Next, we’ll examine how this...
TSE:9432
TSE:9432Telecom

Assessing NTT (TSE:9432) Valuation After MWC 2026 IOWN And Photonics Showcase Announcement

NTT (TSE:9432) is back in the spotlight after announcing that it will showcase its Innovative Optical and Wireless Network (IOWN) and photonics based infrastructure at MWC Barcelona 2026, focusing on AI, networking and energy efficiency. See our latest analysis for NTT. NTT’s latest AI and photonics push at MWC comes after a mixed stretch for the shares, with a 1-year total shareholder return of 8.12%, a year to date share price return of 3.45% and a 5-year total shareholder return of 59.16%...
TSE:9449
TSE:9449IT

Does GMO Internet (TSE:9449) Management Refresh Hint at a Shift in Capital Allocation Priorities?

GMO Internet Group recently held a board meeting to consider establishing an investment limited partnership as a subsidiary, while confirming a refreshed slate of group executive officers, including Founder, Chairman and Group CEO Masatoshi Kumagai and new group executive officer Tatsuki Yamamoto, CFO of GMO Financial Holdings. This combination of governance refinement and potential new investment vehicle highlights management’s focus on tightening oversight across financial services and...
TSE:7261
TSE:7261Auto

Mazda Motor (TSE:7261) Valuation Check After Recent Share Price Weakness

Why Mazda Motor drew fresh attention Mazda Motor (TSE:7261) is back on investors’ radar after recent share price moves, with the stock showing a mix of short term pressure and steadier longer term total returns. See our latest analysis for Mazda Motor. The recent 1-day share price return of a 5.12% decline and 7-day share price return of a 15.87% decline contrast with a 1-year total shareholder return of 16.59%, so short-term momentum appears weaker even as longer-term holders remain...
TSE:7309
TSE:7309Leisure

Shimano (TSE:7309) Valuation Check After Dividend Increase Plan And Rejected Buyback Proposal

Shimano (TSE:7309) is back in the spotlight after two shareholder focused moves: a proposed higher year end dividend for fiscal 2025 and a rejected call for a large, rapid share buyback. See our latest analysis for Shimano. These dividend and buyback debates come after a tougher period for shareholders, with a 1 year total shareholder return of 22.5% decline and a 5 year total shareholder return of 28.9% decline, while the 1 month share price return of 11.3% decline suggests recent momentum...
TSE:4021
TSE:4021Chemicals

Assessing Nissan Chemical (TSE:4021) Valuation After Management Changes And Planned Share Cancellation

Why Nissan Chemical (TSE:4021) Is Back on Investors’ Radar Nissan Chemical (TSE:4021) has drawn attention after announcing broad senior management changes effective April 1, 2026, alongside a board decision to cancel a portion of its own shares, bringing governance and capital allocation into focus. See our latest analysis for Nissan Chemical. The latest senior appointments and the planned share cancellation arrive after a 90 day share price return of 19.95% and a 1 year total shareholder...
TSE:2593
TSE:2593Beverage

Assessing Ito En (TSE:2593) Valuation After Earnings Loss Despite Higher Nine Month Sales

Earnings setback puts Ito En’s recent share performance in focus Ito En (TSE:2593) recently reported nine month earnings to January 31, 2026, with sales of ¥379,477 million and a net loss of ¥88 million, compared with net income a year earlier. See our latest analysis for Ito En. The earnings setback appears to be weighing on sentiment, with a 30 day share price return decline of 3.06% and a year to date share price return decline of 2.77%, while the 5 year total shareholder return decline of...
TSE:4088
TSE:4088Chemicals

Assessing Air Water (TSE:4088) Valuation As Q4 Earnings And Hydrogen Outlook Draw Investor Focus

Air Water (TSE:4088) is back in focus as investors position ahead of its Q4 earnings release, with attention on EPS, operating cash flow, and any commentary on hydrogen and medical supply contracts. See our latest analysis for Air Water. Despite renewed attention ahead of Q4 earnings, Air Water’s 1 month share price return of -16.13% to ¥2,031 contrasts with a 1 year total shareholder return of 8.95%, hinting at fading short term momentum versus still positive longer term outcomes. If this...
TSE:7832
TSE:7832Leisure

Assessing BANDAI NAMCO Holdings (TSE:7832) Valuation After Dividend Cut And Earnings Decline

Why the dividend cut and earnings trend matter for BANDAI NAMCO Holdings BANDAI NAMCO Holdings (TSE:7832) has drawn fresh attention after reporting lower net income for the nine months to December 31, 2025, and revising its full year dividend guidance down to ¥50.00 per share. For investors, the combination of reduced earnings and a lower planned dividend raises questions about capital allocation priorities, the role of shareholder returns in the overall investment case, and how cash flows...
TSE:4506
TSE:4506Pharmaceuticals

A Look At Sumitomo Pharma’s Valuation As AMCHEPRY Wins Conditional Approval And Guidance Rises

Sumitomo Pharma (TSE:4506) just secured conditional Japanese approval for AMCHEPRY, an iPS cell based Parkinson’s therapy, alongside raising its fiscal 2026 earnings guidance and considering a new share issuance, putting the stock firmly on investors’ radar. See our latest analysis for Sumitomo Pharma. The conditional AMCHEPRY approval and raised fiscal 2026 guidance arrive after a volatile period, with a 1 year total shareholder return of 174.36% contrasting with a weaker recent 7 day share...